CrossRef Cited-by Linking Search Results

This Article:

has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking:

  • Functional GIP receptors play a major role in islet compensatory response to high fat feeding in mice
    R. Charlotte Moffett, Srividya Vasu, and Peter R. Flatt
    Biochimica et Biophysica Acta (BBA) - General Subjects (2015) 1850 :1206
  • Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival
    Dawood Khan, Srividya Vasu, R. Charlotte Moffett, Nigel Irwin, and Peter R. Flatt
    Molecular and Cellular Endocrinology (2016) 436 :102
  • A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets
    P. Marchetti, R. Lupi, M. Bugliani, C. L. Kirkpatrick, G. Sebastiani, F. A. Grieco, S. Del Guerra, V. D’Aleo, S. Piro, L. Marselli, U. Boggi, F. Filipponi, L. Tinti, L. Salvini, C. B. Wollheim, F. Purrello, and F. Dotta
    Diabetologia (2012) 55 :3262
  • Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells
    Young-Sun Lee and Hee-Sook Jun
    Metabolism (2014) 63 :9
  • Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice
    Wenjuan Liu, Dong Ok Son, Harry K. Lau, Yinghui Zhou, Gerald J. Prud’homme, Tianru Jin, and Qinghua Wang
    Frontiers in Pharmacology (2017) 8 :
  • GLP-1-related proteins attenuate the effects of mitochondrial membrane damage in pancreatic β cells
    Makiko Ogata, Naoko Iwasaki, Risa Ide, Miho Takizawa, and Yasuko Uchigata
    Biochemical and Biophysical Research Communications (2014) 447 :133
  • Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis
    Divya P. Kumar, Amon Asgharpour, Faridoddin Mirshahi, So Hyun Park, Sichen Liu, Yumi Imai, Jerry L. Nadler, John R. Grider, Karnam S. Murthy, and Arun J. Sanyal
    Journal of Biological Chemistry (2016) 291 :6626
  • Functionality and antidiabetic utility of β- and L-cell containing pseudoislets
    Alastair D. Green, Srividya Vasu, and Peter R. Flatt
    Experimental Cell Research (2016) 344 :201
  • GLP-1-Based Strategies: A Physiological Analysis of Differential Mode of Action
    Rémy Burcelin, Pierre Gourdy, and Stéphane Dalle
    Physiology (2014) 29 :108
  • Pancreatic Beta Cell G-Protein Coupled Receptors and Second Messenger Interactions: A Systems Biology Computational Analysis
    Leonid E. Fridlyand, Louis H. Philipson, and Tao Cai
    PLOS ONE (2016) 11 :e0152869
  • GLP-1 Effects on Islets: Hormonal, Neuronal, or Paracrine?
    M. Y. Donath and R. Burcelin
    Diabetes Care (2013) 36 :S145
  • Insights on glicentin, a promising peptide of the proglucagon family
    Juliette Raffort, Fabien Lareyre, Damien Massalou, Patrick Fénichel, Patricia Panaïa-Ferrari, and Giulia Chinetti
    Biochemia Medica (2017) 27 :308
  • Elevated glucagon-like peptide-1 plasma levels, as a possible adaptive response, in diabetic NOD mice
    T Rydgren, A. Börjesson, A. Carlsson, and S. Sandler
    Biochemical and Biophysical Research Communications (2012) 423 :583
  • Do we know the true mechanism of action of the DPP-4 inhibitors?
    Emilie S. Andersen, Carolyn F. Deacon, and Jens J. Holst
    Diabetes, Obesity and Metabolism (2018) 20 :34
  • Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity
    Giuseppina Opinto, Annalisa Natalicchio, and Piero Marchetti
    Archives of Physiology and Biochemistry (2013) 119 :170
  • desHis1Glu9-glucagon-[mPEG] and desHis1Glu9(Lys30PAL)-glucagon: Long-acting peptide-based PEGylated and acylated glucagon receptor antagonists with potential antidiabetic activity
    Nigel Irwin, Zara J. Franklin, and Finbarr P.M. O'Harte
    European Journal of Pharmacology (2013) 709 :43
  • Peptide Biosynthesis: Prohormone Convertases 1/3 and 2
    Akina Hoshino and Iris Lindberg
    Colloquium Series on Neuropeptides (2012) 1 :1
  • Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line
    Veronica Sancho, Giuseppe Daniele, Daniela Lucchesi, Roberto Lupi, Annamaria Ciccarone, Giuseppe Penno, Cristina Bianchi, Angela Dardano, Roberto Miccoli, Stefano Del Prato, and Nigel Irwin
    PLOS ONE (2017) 12 :e0187836
  • The effect of glucagon-like peptide-1 in the management of diabetes mellitus: cellular and molecular mechanisms
    Mohamed Lotfy, Jaipaul Singh, Hameed Rashed, Saeed Tariq, Erika Zilahi, and Ernest Adeghate
    Cell and Tissue Research (2014) 358 :343
  • Biochemical Basis of the Antidiabetic Activity of Oleanolic Acid and Related Pentacyclic Triterpenes
    J. M. Castellano, A. Guinda, T. Delgado, M. Rada, and J. A. Cayuela
    Diabetes (2013) 62 :1791
  • The sorting of proglucagon to secretory granules is mediated by carboxypeptidase E and intrinsic sorting signals
    R. McGirr, L. Guizzetti, and S. Dhanvantari
    Journal of Endocrinology (2013) 217 :229
  • Progressive change of intra-islet GLP-1 production during diabetes development
    Thomas J. O'Malley, Genevieve E. Fava, Yanqing Zhang, Vivian A. Fonseca, and Hongju Wu
    Diabetes/Metabolism Research and Reviews (2014) 30 :661
  • Differential expression of glucagon-like peptide-2 (GLP-2) is involved in pancreatic islet cell adaptations to stress and beta-cell survival
    Dawood Khan, Srividya Vasu, R. Charlotte Moffett, Nigel Irwin, and Peter R. Flatt
    Peptides (2017) 95 :68
  • The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice
    Yoji Hamada, Hiroshi Nagasaki, Masahiro Fuchigami, Shinji Furuta, Yusuke Seino, Jiro Nakamura, and Yutaka Oiso
    Metabolism (2013) 62 :734
  • Incretin Receptor Null Mice Reveal Key Role of GLP-1 but Not GIP in Pancreatic Beta Cell Adaptation to Pregnancy
    R. Charlotte Moffett, Srividya Vasu, Bernard Thorens, Daniel J. Drucker, Peter R. Flatt, and Christian Holscher
    PLoS ONE (2014) 9 :e96863
  • On-target Effects of GLP-1 Receptor Agonists on Thyroid C-cells in Rats and Mice
    Thomas J. Rosol
    Toxicologic Pathology (2013) 41 :303
  • Alpha cells come of age
    Joel F. Habener and Violeta Stanojevic
    Trends in Endocrinology & Metabolism (2013) 24 :153
  • CREB/CRTC2 controls GLP-1–dependent regulation of glucose homeostasis
    Ji-Hyun Lee, Xianlan Wen, Hana Cho, and Seung-Hoi Koo
    The FASEB Journal (2018) 32 :1566
  • Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion
    Aine M. McKillop, Claire L. Stevenson, Brian M. Moran, Yasser H.A. Abdel-Wahab, and Peter R. Flatt
    Peptides (2018) 100 :165
  • α-cell role in β-cell generation and regeneration
    Joel F. Habener and Violeta Stanojevic
    Islets (2012) 4 :188
  • The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice
    Adam P. Chambers, Joyce E. Sorrell, April Haller, Karen Roelofs, Chelsea R. Hutch, Ki-Suk Kim, Ruth Gutierrez-Aguilar, Bailing Li, Daniel J. Drucker, David A. D’Alessio, Randy J. Seeley, and Darleen A. Sandoval
    Cell Metabolism (2017) 25 :927
    Everton CAZZO, José Carlos PAREJA, Elinton Adami CHAIM, Cláudio Saddy Rodrigues COY, and Daniéla Oliveira MAGRO
    Arquivos de Gastroenterologia (2018) 55 :72
  • Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells
    Salvatore Piro, Loriana G. Mascali, Francesca Urbano, Agnese Filippello, Roberta Malaguarnera, Salvatore Calanna, Agata M. Rabuazzo, Francesco Purrello, and Francesco Giorgino
    PLoS ONE (2014) 9 :e90093
  • Oleanolic Acid Improves Gut Atrophy Induced by Parenteral Nutrition
    Ajay Kumar Jain, Joy X. Wen, Keith S. Blomenkamp, Sumit Arora, Timothy A. Blaufuss, Jonathan Rodrigues, John P. Long, Brent A. Neuschwander-Tetri, and Jeffery H. Teckman
    Journal of Parenteral and Enteral Nutrition (2016) 40 :67
  • Naturally-occurring TGR5 agonists modulating glucagon-like peptide-1 biosynthesis and secretion
    Laila Jafri, Samreen Saleem, Danielle Calderwood, Anna Gillespie, Bushra Mirza, and Brian D. Green
    Peptides (2016) 78 :51
  • GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans
    Virginia M. Stone, Shalinee Dhayal, Katy J. Brocklehurst, Carol Lenaghan, Maria Sörhede Winzell, Mårten Hammar, Xiufeng Xu, David M. Smith, and Noel G. Morgan
    Diabetologia (2014) 57 :1182
  • Role of Endogenous GLP-1 and GIP in Beta Cell Compensatory Responses to Insulin Resistance and Cellular Stress
    Srividya Vasu, R. Charlotte Moffett, Bernard Thorens, Peter R. Flatt, and Nigel Irwin
    PLoS ONE (2014) 9 :e101005
  • The multifaceted role of natriuretic peptides in metabolic syndrome
    Prasanna K. Santhekadur, Divya P. Kumar, Mulugeta Seneshaw, Faridoddin Mirshahi, and Arun J. Sanyal
    Biomedicine & Pharmacotherapy (2017) 92 :826
  • Candidate Genes Expressed in Human Islets and Their Role in the Pathogenesis of Type 1 Diabetes
    Joachim Storling and Caroline Anna Brorsson
    Current Diabetes Reports (2013) 13 :633
  • A 4-week study assessing the pharmacokinetics, pharmacodynamics, safety, and tolerability of the glucagon receptor antagonist PF-06291874 administered as monotherapy in subjects with type 2 diabetes mellitus
    Arthur Bergman, Beesan Tan, Veena R. Somayaji, Roberto A. Calle, and David J. Kazierad
    Diabetes Research and Clinical Practice (2017) 126 :95
  • Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
    Darleen A. Sandoval and David A. D'Alessio
    Physiological Reviews (2015) 95 :513
  • Intra-islet glucagon-like peptide 1
    Genevieve E. Fava, Emily W. Dong, and Hongju Wu
    Journal of Diabetes and its Complications (2016) 30 :1651
  • Pancreatic β-Cell Proliferation in Obesity
    Amelia K. Linnemann, Mieke Baan, and Dawn Belt Davis
    Advances in Nutrition (2014) 5 :278
  • Modified Western blotting for insulin and other diabetes-associated peptide hormones
    Naoyuki Okita, Yoshikazu Higami, Fumio Fukai, Masaki Kobayashi, Miku Mitarai, Takao Sekiya, and Takashi Sasaki
    Scientific Reports (2017) 7 :
  • Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats
    Sarah W. Lai, Elaine de Heuvel, Laurie E. Wallace, Bolette Hartmann, Jens J. Holst, Mary E. Brindle, Prasanth K. Chelikani, David L. Sigalet, and Xuan-Zheng Shi
    PLOS ONE (2017) 12 :e0181453
  • Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors)
    Derek J. Nunez and David D'Alessio
    Diabetes, Obesity and Metabolism (2018) 20 :233
  • Decreased serum glicentin concentration in patients with severe and morbid obesity
    Juliette Raffort, Patricia Panaïa-Ferrari, Fabien Lareyre, Mathilde Blois, Pascale Bayer, Pascal Staccini, Patrick Fénichel, and Giulia Chinetti
    Annals of Clinical Biochemistry: International Journal of Laboratory Medicine (2018) 55 :198
  • Peptidomic Profiling of Secreted Products from Pancreatic Islet Culture Results in a Higher Yield of Full-length Peptide Hormones than Found using Cell Lysis Procedures
    Steven W. Taylor, Svetlana E. Nikoulina, Nancy L. Andon, and Carolyn Lowe
    Journal of Proteome Research (2013) 12 :3610
  • Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism
    Erin E. Mulvihill
    Peptides (2018) 100 :158
  • Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies
    Christof M. Kazda, Ying Ding, Ronan P. Kelly, Parag Garhyan, Chunxue Shi, Chay Ngee Lim, Haoda Fu, David E. Watson, Andrew J. Lewin, William H. Landschulz, Mark A. Deeg, David E. Moller, and Thomas A. Hardy
    Diabetes Care (2016) 39 :1241
  • Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders
    Nader H. Moniri
    Biochemical Pharmacology (2016) 110-111 :1
  • Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research
    Ang Li, Yue Li, and Lupei Du
    Future Medicinal Chemistry (2015) 7 :1457
  • Evolving function and potential of pancreatic alpha cells
    Violeta Stanojevic and Joel F. Habener
    Best Practice & Research Clinical Endocrinology & Metabolism (2015) 29 :859
  • Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice
    Nigel Irwin, Ian A. Montgomery, R. Charlotte Moffett, and Peter R. Flatt
    Biochemical Pharmacology (2013) 85 :81
  • A synopsis of factors regulating beta cell development and beta cell mass
    Krishna Prasadan, Chiyo Shiota, Xiao Xiangwei, David Ricks, Joseph Fusco, and George Gittes
    Cellular and Molecular Life Sciences (2016) 73 :3623
  • GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic  -cells from glucolipotoxicity
    Z. Liu, V. Stanojevic, L. J. Brindamour, and J. F. Habener
    Journal of Endocrinology (2012) 213 :143
  • Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes
    R. P. Kelly, P. Garhyan, E. Raddad, H. Fu, C. N. Lim, M. J. Prince, J. A. Pinaire, M. T. Loh, and M. A. Deeg
    Diabetes, Obesity and Metabolism (2015) 17 :414